Form 4 Walsh Jeffrey T.

4 - Statement of changes in beneficial ownership of securities

Published: 2017-05-12 16:20:33
Submitted: 2017-05-12
Period Ending In: 2017-05-10
doc4.html FORM 4 SUBMISSION


>

SEC FORM 4

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Walsh Jeffrey T.

(Last) (First) (Middle)
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
bluebird bio, Inc. [ BLUE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) X Other (specify below)
Chief Financial / and Strategy Officer
3. Date of Earliest Transaction (Month/Day/Year)
05/10/2017
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/10/2017 M 1,250 A $5.5004 28,555 D
Common Stock 05/10/2017 S(1) 1,247 D $88.7715(2) 27,308 D
Common Stock 05/10/2017 S(1) 3 D $89.4333(3) 27,305 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $5.5004 05/10/2017 M 1,250 (4) 01/16/2023 Common Stock 1,250 $0.00 89,385 D
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2016.
2. The range of prices for the transaction reported on this line was $88.15 to $88.95. The average weighted price was $88.7715. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3. The range of prices for the transaction reported on this line was $89.40 to $89.45. The average weighted price was $89.4333. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
4. This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of May 1, 2013. The shares underlying these options vested as follows: 25% vested on May 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.
Remarks:
/s/ Jason F. Cole, Attorney-in-Fact 05/12/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
1
doc4.xml FORM 4 SUBMISSION
Schema Version:
X0306
Document Type:
4
Period Of Report:
2017-05-10
Not Subject To Section16:
0

Issuer

Issuer Cik
0001293971
Issuer Name
bluebird bio, Inc.
Issuer Trading Symbol
BLUE

Reporting Owner

Reporting Owner Id

Rpt Owner Cik
0001578251
Rpt Owner Name
Walsh Jeffrey T.

Reporting Owner Address

Rpt Owner Street1
C/O BLUEBIRD BIO, INC.
Rpt Owner Street2
60 BINNEY STREET
Rpt Owner City
CAMBRIDGE
Rpt Owner State
MA
Rpt Owner Zip Code
02142

Reporting Owner Relationship

Is Director
0
Is Officer
1
Is Ten Percent Owner
0
Is Other
1
Officer Title
Chief Financial
Other Text
and Strategy Officer

Non Derivative Transaction

Security Title
Common Stock
Transaction Date
2017-05-10

Transaction Coding

Transaction Form Type
4
Transaction Code
M
Equity Swap Involved
0

Transaction Amounts

Transaction Shares
1250
Transaction Price Per Share
5.5004
Transaction Acquired Disposed Code
A
Shares Owned Following Transaction
28555
Direct Or Indirect Ownership
D
Security Title
Common Stock
Transaction Date
2017-05-10

Transaction Coding

Transaction Form Type
4
Transaction Code
S
Equity Swap Involved
0
@attributes Id
F1

Transaction Amounts

Transaction Shares
1247

Transaction Price Per Share

Value
88.7715
@attributes Id
F2
Transaction Acquired Disposed Code
D
Shares Owned Following Transaction
27308
Direct Or Indirect Ownership
D
Security Title
Common Stock
Transaction Date
2017-05-10

Transaction Coding

Transaction Form Type
4
Transaction Code
S
Equity Swap Involved
0
@attributes Id
F1

Transaction Amounts

Transaction Shares
3

Transaction Price Per Share

Value
89.4333
@attributes Id
F3
Transaction Acquired Disposed Code
D
Shares Owned Following Transaction
27305
Direct Or Indirect Ownership
D

Derivative Transaction

Security Title
Stock Option (right to buy)
Conversion Or Exercise Price
5.5004
Transaction Date
2017-05-10

Transaction Coding

Transaction Form Type
4
Transaction Code
M
Equity Swap Involved
0

Transaction Amounts

Transaction Shares
1250
Transaction Price Per Share
0.00
Transaction Acquired Disposed Code
D
@attributes Id
F4
Expiration Date
2023-01-16

Underlying Security

Underlying Security Title
Common Stock
Underlying Security Shares
1250
Shares Owned Following Transaction
89385
Direct Or Indirect Ownership
D

Footnote

0
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2016.
1
The range of prices for the transaction reported on this line was $88.15 to $88.95. The average weighted price was $88.7715. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2
The range of prices for the transaction reported on this line was $89.40 to $89.45. The average weighted price was $89.4333. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3
This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of May 1, 2013. The shares underlying these options vested as follows: 25% vested on May 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.

Owner Signature

Signature Name
/s/ Jason F. Cole, Attorney-in-Fact
Signature Date
2017-05-12
Additional Files
FileSequenceDescriptionTypeSize
0001209191-17-031936.txt   Complete submission text file   11323
$BLUE

© 2019 SEC.report
SEC CFR Title 17 of the Code of Federal Regulations.